BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 236 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,546 | +2.1% | 33,128 | +1.6% | 0.00% | 0.0% |
| Q2 2023 | $229,659 | +27.6% | 32,622 | +128.4% | 0.00% | 0.0% |
| Q3 2022 | $180,000 | -42.9% | 14,285 | -53.8% | 0.00% | 0.0% |
| Q1 2021 | $315,000 | -76.3% | 30,950 | -82.6% | 0.00% | -83.3% |
| Q4 2020 | $1,329,000 | +198.7% | 178,325 | +37.7% | 0.01% | +200.0% |
| Q3 2020 | $445,000 | +12.7% | 129,470 | +56.1% | 0.00% | 0.0% |
| Q2 2020 | $395,000 | +66.0% | 82,955 | -30.4% | 0.00% | 0.0% |
| Q1 2020 | $238,000 | -22.5% | 119,180 | +33.8% | 0.00% | 0.0% |
| Q4 2019 | $307,000 | +132.6% | 89,050 | +253.8% | 0.00% | +100.0% |
| Q3 2017 | $132,000 | +13.8% | 25,170 | +95.7% | 0.00% | 0.0% |
| Q1 2015 | $116,000 | – | 12,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |